Puretech Health Plc - Adr Share Price: PRTC (Puretech Health Plc - Adr) Stock Price Today & Updates | INDmoney

Question 1

What is Puretech Health Plc - Adr share price today?

Accepted Answer

Puretech Health Plc - Adr (PRTC) share price today is {{live_price}}.

Question 2

Can Indians buy Puretech Health Plc - Adr shares?

Accepted Answer

Yes, Indians can invest in the Puretech Health Plc - Adr (PRTC) from India.

With INDmoney, you can buy Puretech Health Plc - Adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Puretech Health Plc - Adr at zero transaction cost.

Question 3

How can I buy Puretech Health Plc - Adr shares from India?

Accepted Answer

It is very easy to buy Puretech Health Plc - Adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Puretech Health Plc - Adr be purchased?

Accepted Answer

Yes, you can buy fractional shares of Puretech Health Plc - Adr with INDmoney app.

Question 5

What are the documents required to start investing in Puretech Health Plc - Adr stocks?

Accepted Answer

To start investing in Puretech Health Plc - Adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Puretech Health Plc - Adr

Accepted Answer

Today’s highest price of Puretech Health Plc - Adr (PRTC) is {{1_rba_end}}.

Today’s lowest price of Puretech Health Plc - Adr (PRTC) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Puretech Health Plc - Adr

Accepted Answer

Today's market capitalisation of Puretech Health Plc - Adr PRTC is 705.9M

Question 8

What is the 52 Week High and Low Range of Puretech Health Plc - Adr

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Puretech Health Plc - Adr is down from its 52 Week High?

Accepted Answer

Puretech Health Plc - Adr (PRTC) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Puretech Health Plc - Adr is up from its 52 Week low?

Accepted Answer

Puretech Health Plc - Adr (PRTC) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Puretech Health Plc - Adr?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Puretech Health Plc - Adr

Accepted Answer

Ms. Daphne  Zohar is the current Chief Executive Officer (CEO) of Puretech Health Plc - Adr.

Period	Puretech Health Plc - Adr	Sector (Health Care)	Index (Russel 2000)
3 Months	8.87%	1.7%	0.0%
6 Months	40.56%	11.3%	0.0%
1 Year	3.27%	5.4%	1.3%
3 Years	-43.86%	13.9%	-22.1%

Market Capitalization	705.9M
Book Value	$1.86
Earnings Per Share (EPS)	-1.7
Wall Street Target Price	58.0

Profit Margin	0.0%
Operating Margin TTM	-2417.84%

Return On Assets TTM	-14.24%
Return On Equity TTM	-7.22%

Revenue TTM	11.7M
Revenue Per Share TTM	0.42
Quarterly Revenue Growth YOY	-55.2%
Gross Profit TTM	17.4M
EBITDA	-168.2M
Diluted Eps TTM	-1.7
Quarterly Earnings Growth YOY	0.62

Puretech Health Plc - Adr (PRTC)

Decreasing Revenue

Decreasing Net Profit

Vs NVO

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Puretech Health Plc - Adr Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	0.0
EPS Estimate Next Year	0.0
EPS Estimate Current Quarter	0.0
EPS Estimate Next Quarter	0.0

	FY17	Y/Y Change
Revenue	650.0K	↓ 85.33%
Net Income	30.9M	↓ 163.27%
Net Profit Margin	4.7K%	↑ 5850.23%

	FY18	Y/Y Change
Revenue	16.4M	↑ 2418.62%
Net Income	-43.7M	↓ 241.42%
Net Profit Margin	-266.65%	↓ 5015.73%

	FY19	Y/Y Change
Revenue	8.7M	↓ 46.93%
Net Income	421.1M	↓ 1064.73%
Net Profit Margin	4.8K%	↑ 5114.07%

	FY20	Y/Y Change
Revenue	8.3M	↓ 3.99%
Net Income	4.6M	↓ 98.92%
Net Profit Margin	54.77%	↓ 4792.65%

	FY21	Y/Y Change
Revenue	10.0M	↑ 19.64%
Net Income	-62.7M	↓ 1472.79%
Net Profit Margin	-628.41%	↓ 683.18%

	FY22	Y/Y Change
Revenue	2.1M	↓ 79.06%
Net Income	-37.1M	↓ 40.9%
Net Profit Margin	-1.8K%	↓ 1144.99%

	Q3 FY22	Q/Q Change
Revenue	4.3M	↓ 38.93%
Net Income	-11.0M	↓ 61.17%
Net Profit Margin	-256.32%	↑ 146.87%

	Q2 FY23	Q/Q Change
Revenue	3.2M	↓ 65.03%
Net Income	-25.0M	↑ 8.3%
Net Profit Margin	-793.81%	↓ 537.51%

	FY17	Y/Y Change
Total Assets	339.8M	↑ 13.76%
Total Liabilities	275.8M	↑ 33.69%

	FY17	Y/Y Change
Operating Cash Flow	-88.7M	↑ 52.82%
Investing Cash Flow	83.7M	↓ 293.57%
Financing Cash Flow	14.7M	↓ 50.16%

	FY18	Y/Y Change
Operating Cash Flow	-72.8M	↓ 17.92%
Investing Cash Flow	-39.6M	↓ 147.38%
Financing Cash Flow	156.9M	↑ 967.55%

	FY19	Y/Y Change
Operating Cash Flow	-98.2M	↑ 34.84%
Investing Cash Flow	63.7M	↓ 260.57%
Financing Cash Flow	49.9M	↓ 68.19%

	FY20	Y/Y Change
Operating Cash Flow	-131.8M	↑ 34.3%
Investing Cash Flow	364.5M	↑ 472.55%
Financing Cash Flow	38.9M	↓ 22.12%

	FY18	Y/Y Change
Total Assets	441.8M	↑ 29.99%
Total Liabilities	274.8M	↓ 0.38%

	FY19	Y/Y Change
Total Assets	941.2M	↑ 113.05%
Total Liabilities	290.8M	↑ 5.82%

	FY20	Y/Y Change
Total Assets	990.0M	↑ 5.19%
Total Liabilities	336.5M	↑ 15.71%

	FY22	Y/Y Change
Total Assets	702.6M	↓ 25.72%
Total Liabilities	155.1M	↓ 57.15%

	Q2 FY22	Q/Q Change
Total Assets	823.2M	↓ 12.99%
Total Liabilities	247.1M	↓ 31.71%

	Q3 FY22	Q/Q Change
Total Assets	702.6M	↓ 14.64%
Total Liabilities	155.1M	↓ 37.26%

	Q2 FY23	Q/Q Change
Total Assets	693.6M	↓ 1.29%
Total Liabilities	184.7M	↑ 19.09%

	FY21	Y/Y Change
Operating Cash Flow	-158.3M	↑ 20.06%
Investing Cash Flow	197.4M	↓ 45.85%
Financing Cash Flow	22.7M	↓ 41.53%

	Q1 FY22	Q/Q Change
Operating Cash Flow	-43.6M	↓ 6.09%
Investing Cash Flow	-3.4M	↓ 108.35%
Financing Cash Flow	-2.8M	↓ 115.55%

	Q2 FY22	Q/Q Change
Operating Cash Flow	-87.2M	↑ 100.0%
Investing Cash Flow	-3.4M	↑ 0.0%
Financing Cash Flow	-5.7M	↑ 100.0%

	Q3 FY22	Q/Q Change
Operating Cash Flow	-45.8M	↓ 47.54%
Investing Cash Flow	86.9M	↓ 2625.93%
Financing Cash Flow	-12.1M	↑ 113.26%

	Q4 FY22	Q/Q Change
Operating Cash Flow	-32.6M	↓ 28.85%
Investing Cash Flow	86.9M	↑ 0.0%
Financing Cash Flow	45.9M	↓ 480.34%

	Q1 FY23	Q/Q Change
Operating Cash Flow	-100.3M	↑ 207.97%
Investing Cash Flow	86.9M	↑ 0.0%
Financing Cash Flow	-25.6M	↓ 155.76%

	Q2 FY23	Q/Q Change
Operating Cash Flow	-65.1M	↓ 35.06%
Investing Cash Flow	86.9M	↑ 0.0%
Financing Cash Flow	91.9M	↓ 458.66%

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Puretech Health Plc - Adr	-4.45%	40.56%	3.27%	-43.86%	-43.86%
Moderna, Inc.	-1.39%	41.81%	-19.31%	-38.71%	322.88%
Regeneron Pharmaceuticals, Inc.	-5.68%	13.74%	14.81%	80.88%	159.02%
Novo Nordisk A/s	-2.24%	29.49%	49.67%	240.51%	421.0%
Vertex Pharmaceuticals Incorporated	-3.67%	10.39%	20.74%	84.71%	129.52%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Puretech Health Plc - Adr	NA	NA	NA	0.0	-0.07	-0.14	NA	1.86
Moderna, Inc.	24.73	NA	0.0	-6.77	-0.29	-0.12	NA	36.27
Regeneron Pharmaceuticals, Inc.	26.13	26.13	1.46	45.02	0.16	0.08	NA	242.47
Novo Nordisk A/s	48.36	48.36	2.4	3.34	0.88	0.23	0.01	23.9
Vertex Pharmaceuticals Incorporated	29.17	29.17	0.53	16.75	0.23	0.13	NA	68.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Puretech Health Plc - Adr	Buy	$705.9M	-43.86%	NA	0.0%
Moderna, Inc.	Buy	$41.3B	322.88%	24.73	-68.84%
Regeneron Pharmaceuticals, Inc.	Buy	$99.6B	159.02%	26.13	30.14%
Novo Nordisk A/s	Buy	$573.9B	421.0%	48.36	36.03%
Vertex Pharmaceuticals Incorporated	Buy	$104.7B	129.52%	29.17	36.68%

Organization	Puretech Health Plc - Adr
Employees	111
CEO	Ms. Daphne Zohar
Industry	Health Technology